Drug Development Services China

As one of the world’s largest drug development companies, Covance can deliver integrated, in-country solutions. From lead optimization to commercialization, you can count on our local insight and global expertise to move your product forward. 

  • Maximize development ROI with integrated local and global solutions 

  • Faster recruitment with access to investigators and patients in more than 100 countries worldwide

  • Consistent, high quality data through global SOPs, platforms and standards across central laboratories 

Picture of a drug development scientist in Covance China.
Solutions in China

At Covance, we work as your resourceful partner to provide innovative solutions, share unique perspectives and deliver quality results. Learn more about how you can save time and experience new cost efficiencies by accessing our integrated solutions. 

Local Expertise

Partner with our network of regulatory experts, solution directors and program managers to meet your needs in regulatory filling both in China and globally. With accumulated experience, we provide insights to help you reach decision points faster. 

  • Regulatory support: Approval times in China are among the longest in the world. Get experienced consulting with your product development plan and regulatory submissions from our regulatory personnel who have years of product development experience and proactively stay abreast of the latest regulatory changes. Register your compound in the U.S., European and the rest of the world with the support of our skilled regulatory staff who have extensive experience interacting with CFDA, FDA, EMA and other Health Authorities globally.
  • Program management: Gain insight and support from our program management team to proactively reveal opportunities for your molecule.
  • In-country expertise: leverage our scientific, regulatory and operational expertise across the development continuum for informed insights that deliver decision driving data.

With a powerful economy, large population and strong talent pool, China is quickly becoming a leading region for R&D. Consider other factors in China’s drug development and clinical trial landscape:

  • Extensive growth: Viewed as a key emerging market for multinational pharmaceutical companies with an increase in clinical trials activity, China is expected to become a leading pharmaceutical consumer in the next few years.
  • Accessible patients: China holds great potential to reach a large number of treatment-naïve patients, a growing elderly population and diverse ethnic groups in a relatively low-cost environment. 

Whether running a global trial in China, bringing a product into China or introducing a domestic product to the Western markets, we are ready to deliver your results.

Sales Enquiries:
+86 021 6807 8700

General Enquiries:
+86 10 5732 3000 Beijing
+86 21 6171 1200 Shanghai

Office Address:
Covance Pharmaceutical Research and Development (Beijing) Co. Ltd.
Units 1501-1508, Tower A,
Gemdale Plaza, No.91,
JianGuo Road,
Chaoyang District,
Beijing 100022 China

Covance Pharmaceutical Research and Development (Shanghai) Co., Ltd.
Rm1806, Raffles City,No.268 Xizang (M) Road,
Huangpu District Shanghai
86-21 61711200
86-21 63403027 Fax

Covance Pharmaceutical Research and Development (Shanghai) Co., Ltd.
Building #3, No. 3377 Kangxin Rd.
SIMZ Pudong
Shanghai 201318, China

Covance Pharmaceutical Research and Development (Shanghai) Co., Ltd.
1st Floor, No. 6 Building,
No. 151 Li Bing Road,
Zhangjiang Hi-Tech Park
Shanghai 201203 P.R. China
86-21 61711200
86-21 643403027 Fax

Covance Pharmaceutical R&D (Beijing) Co., Ltd.
Shanghai Branch
Rm 602-606, Central Tower A
No. 555 Langao Road, Putuo District
Shanghai 200333, China